Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Neoplasms 5 Stomach Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thromboembolism 1 Thrombocytopenia 1 Stomatitis 1 Spondylitis, Ankylosing 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Scleroderma, Localized 1 Psoriasis 1 Postoperative Hemorrhage 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Pancreatic Cyst 1 Pain, Postoperative 1 Pain 1

Interventions

Surveys and Questionnaires 2 Analgesics, Opioid 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 acetaminophen, aspirin, caffeine drug combination 1 Uterine Myomectomy 1 Transcutaneous Electric Nerve Stimulation 1 Therapeutics 1 Tea 1 Tapentadol 1 Saline Solution 1 Ropivacaine 1 Propofol 1 Nerve Block 1 Meperidine 1 Lidocaine 1 Ketamine 1 Injections, Subcutaneous 1 Fentanyl 1 Anesthetics, Local 1 Anesthesia, Local 1 Anesthesia, General 1 Analgesia, Patient-Controlled 1 Acupuncture Therapy 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Agnosia × Saline Solution × Clear all

NCT00210210 2025-09-19

KETAMINE

Institut Bergonié

Phase 3 Completed

230 enrolled 6 charts

Agnosia, Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡